Gynecologic Oncology
Comprehensive Gynecologic Cancer Care — Advanced Surgery, Precision Medicine, Personalized Support.
Robotic and fertility-sparing surgery, targeted systemic therapy, and survivorship programs for cancers of the ovary, uterus, cervix, vulva, and vagina.
The Gynecologic Oncology Service offers comprehensive cancer care that includes high-ADR screening colonoscopy, advanced endoscopic resection (EMR/ESD), EUS & ERCP staging, cutting-edge imaging (PET-CT, MRI liver protocols), molecular profiling, minimally invasive and robotic surgery, organ-preservation protocols, liver-directed therapies (TACE, Y-90), and state-of-the-art systemic and radiation therapies. Our weekly Gyne-Onc Tumor Board ensures every patient receives a personalized, guideline-based treatment plan.
1,150+
gynecologic cancer cases treated in 202478%
of resections for early-stage disease performed using minimally invasive or robotic techniques<7
days from biopsy to multidisciplinary treatment plan23
active Phase I–III clinical trials, including PARP inhibitors, ADC, and immunotherapyCommon Conditions & Subspecialty Clinics.
- Epithelial ovarian cancer
- Germ-cell tumors
- Sex-cord stromal tumors
- Secondary cytoreductive surgery
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Endometrial carcinoma
- Uterine sarcoma
- Cervical squamous-cell carcinoma and adenocarcinoma
- Fertility-sparing trachelectomy
- Vulvar squamous-cell carcinoma
- Paget disease of the vulva
- Bartholin-gland carcinoma
- Vaginal cancer
- Complete and partial hydatidiform mole
- Choriocarcinoma
- Placental-site trophoblastic tumor
- hCG surveillance and chemotherapy
- Oocyte and embryo cryopreservation
- Ovarian tissue freezing
- Ovarian transposition prior to pelvic radiation or surgery
- BRCA1/2, Lynch syndrome, RAD51C/D mutation carriers
- Risk-reducing surgery (e.g., salpingo-oophorectomy, hysterectomy)
- Surveillance and chemoprevention
Procedures & Treatments.
Pelvic Exenteration & Complex Reconstruction with plastic surgery support
Fertility-Sparing Surgery – Radical trachelectomy, unilateral oophorectomy, cystectomy
HIPEC (intraperitoneal heated chemotherapy) during interval debulking
Sentinel-Node Mapping using ICG and near-infrared imaging
Robotic or Laparoscopic Cytoreductive Surgery with fluorescence perfusion
Robotic Radical Hysterectomy & Lymphadenectomy (da Vinci Xi)
Hormonal Therapy – Progestins, aromatase inhibitors for low-grade endometrioid carcinoma
Immunotherapy – PD-1 inhibitors for MSI-H/dMMR endometrial & PD-L1+ cervical cancers
Antibody-Drug Conjugates (mirvetuximab, tisotumab) for recurrent disease
PARP Inhibitors (olaparib, niraparib) maintenance for BRCA & HRD tumors
Platinum/Taxane Chemotherapy with dose-dense and intraperitoneal options
SBRT boost for oligometastatic lesions
Image-Guided Adaptive Brachytherapy (3-D MRI-based) for cervix & vault
IMRT / VMAT pelvic radiation with bowel-sparing techniques
Genetic counseling & cascade testing for hereditary syndromes
Lymphedema prevention & management clinic
Sexual health and pelvic-floor rehabilitation
Onco-fertility counseling and ovarian suppression
Care Pathway & Coordination.
Rapid Referral & Diagnostics
Pelvic MRI, PET-CT, tumor markers, biopsy within 5 days.
GI Tumor Board
Consensus plan (surgery, neoadjuvant, systemic, trials).
Treatment Phase
Timely start of therapy; nurse navigator coordinates appointments.
Response Assessment
Imaging labs per protocol; ctDNA monitoring.
Surgery / Intervention
Minimally invasive resection or liver-directed therapy.
Survivorship Follow-up
Surveillance schedule, wellness programs, rapid re-entry for recurrence.
Technology & Facilities.
da Vinci Xi Robotic Suites with Firefly ICG Imaging
Hybrid OR & Intra-operative CT for complex resections
3-T Pelvic MRI & 64-slice PET-CT for precise staging
MRI-Guided Brachytherapy Suite
Real-time applicator placement
On-site Genomics Lab
HRD, MSI, and comprehensive NGS panels
Fertility Preservation Lab
Oocyte/embryo cryostorage, ovarian tissue cryobank
